文献速递区域麻醉与超声疼痛医学

超声引导膝神经阻滞用于全膝关节置换术的随机双盲安慰剂对照试验

Ultrasound-guided genicular nerve blocks following total knee arthroplasty: a randomized, double-blind, placebo-controlled trial.
PubMed 文献 · Reg Anesth Pain Med · 2021-07-14

这项随机双盲安慰剂对照试验纳入40例初次全膝关节置换术患者,在标准多模式镇痛基础上比较膝神经阻滞与安慰剂。结果显示阻滞组24小时阿片消耗量显著低于假组(23±20 vs 58±35,p<0.001),48小时差异仍显著,6小时疼痛评分降低,但患者满意度和步行测试无差异。

要点

  • 膝神经阻滞可显著降低全膝关节置换术后24小时和48小时阿片消耗量
  • 阻滞组仅在术后6小时疼痛评分降低,其余时间点无差异
  • 患者满意度和20米步行测试时间两组无差异

核心结论

  • 在初次全膝关节置换术中,膝神经阻滞与24小时阿片消耗量降低相关,48小时差异仍显著。

研究设计与样本

  • 随机双盲安慰剂对照试验,纳入40例ASA 1-3级、18-85岁行初次全膝关节置换术的患者。

主要发现

  • 24小时阿片消耗量阻滞组显著低于假组(23±20 vs 58±35,p<0.001)。
  • 48小时阿片消耗量差异仍显著(50±40 vs 98±56,p=0.004)。
  • 6小时疼痛评分阻滞组降低(2.6±1.9 vs 4.3±2.2,p=0.012),其余时间点相似。
  • 24小时患者满意度和20米步行测试时间两组相似。

关键数值与推荐

  • 膝神经阻滞使用15 mL 0.25%布比卡因加2 mg地塞米松或15 mL生理盐水安慰剂,注射于股外侧、股内侧和股内侧下膝神经。
  • 所有患者接受标准口服镇痛方案、12.5 mg等比重布比卡因腰麻、0.2%罗哌卡因腘动脉与膝关节囊间浸润及术后0.2%罗哌卡因收肌管神经周围输注。

临床怎么用

  • 对于初次全膝关节置换术患者,可在标准多模式镇痛基础上联合超声引导膝神经阻滞以减少术后阿片消耗。

局限性

  • 样本量较小(40例),可能影响次要结局的统计效能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Local anesthetic blockade of the genicular nerves, known targets of radiofrequency ablative techniques for knee pain, has not previously been studied in a randomized controlled trial evaluating acute pain after knee arthroplasty. We hypothesized that genicular nerve blockade added to an existing block regimen in total knee arthroplasty would result in a reduction in 24 hours opioid consumption. METHODS: Patients (American Society of Anesthesiologists 1-3, aged 18-85 years) undergoing primary total knee arthroplasty were randomized to receive single-injection nerve blocks of the superolateral, superomedial, and inferomedial genicular nerves with injectate (15 mL 0.25% bupivacaine and 2 mg dexamethasone or 15 mL saline placebo). All subjects received a standard oral analgesic regimen, spinal anesthetic with 12.5 mg isobaric bupivacaine, infiltration between the popliteal artery and capsule of the knee with 0.2% ropivacaine, and postoperative adductor canal perineural infusion with 0.2% ropivacaine. The primary outcome was 24 hours opioid consumption (measured in morphine milliequivalents). RESULTS: Forty (40) subjects were enrolled. Opioid consumption at 24 hours was significantly lower in the BLOCK group compared with the SHAM group (23±20 vs 58±35, p<0.001), and this difference remained significant at 48 hours (50±40 vs 98±56, p=0.004). Pain scores were reduced in the BLOCK group at time 6 hours (2.6±1.9 vs 4.3±2.2, p=0.012), but were otherwise similar at remaining time points. Patient satisfaction at 24 hours and 20 m walk test times were similar between groups. DISCUSSION: Genicular nerve blockade was associated with a reduction in opioid consumption at 24 hours in primary total knee arthroplasty patients. TRIAL REGISTRATION NUMBER: NCT03706313.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Rambhia M, Chen A, Kumar AH, et al. Ultrasound-guided genicular nerve blocks following total knee arthroplasty: a randomized, double-blind, placebo-controlled trial. Reg Anesth Pain Med. 2021. PMID: 34261807. doi:10.1136/rapm-2021-102667

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。